Successful Management of Reversible Cerebral Vasoconstriction Syndrome-Induced Intracerebral Hemorrhage with Minimally Invasive Surgery Plus Recombinant Tissue-Type Plasminogen Activator
نویسندگان
چکیده
RCVS: Reversible Cerebral Vasoconstriction Syndrome; rtPA: recombinant tissue Plasminogen Activator; GCS: Glasgow Coma Scale; CT: Computed Tomography; ICH: Intracerebral Hemorrhage; MRI: Magnetic Resonance Imaging; MRR: MR Renography; ACA: Anterior Cerebral Artery; MIS: Minimally Invasive Surgery; TCD: Transcranial Doppler; ICU: Intensive Care Unit; MISTIE: Minimally Invasive Surgery plus rt-PA in the Treatment of Intracerebral hemorrhage; SAH: Subarachnoid Hemorrhage
منابع مشابه
Safety and efficacy of minimally invasive surgery plus recombinant tissue plasminogen activator in intracerebral haemorrhage evacuation (MISTIE): a randomised, phase 2 trial
BACKGROUND Craniotomy, according to the results from trials, does not improve functional outcome after intracerebral haemorrhage. Whether minimally invasive catheter evacuation followed by thrombolysis for clot removal is safe and can achieve a good functional outcome is not known. We investigated the safety and efficacy of alteplase, a recombinant tissue plasminogen activator, in combination w...
متن کاملMinimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema.
BACKGROUND AND PURPOSE Perihematomal edema (PHE) can worsen outcomes after intracerebral hemorrhage (ICH). Reports suggest that blood degradation products lead to PHE. We hypothesized that hematoma evacuation will reduce PHE volume and that treatment with recombinant tissue-type plasminogen activator (rt-PA) will not exacerbate it. METHODS Minimally invasive surgery and rt-PA in ICH evacuatio...
متن کاملLow-dose intravenous recombinant tissue-type plasminogen activator therapy for patients with stroke outside European indications: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rtPA Registry.
BACKGROUND AND PURPOSE The purpose of this study was to determine the safety and efficacy of intravenous recombinant tissue-type plasminogen activator (0.6 mg/kg alteplase) within 3 hours of stroke onset in Japanese patients outside the indications in the European license. METHODS Of the 600 patients who were treated with recombinant tissue-type plasminogen activator, 422 met the inclusion cr...
متن کاملThrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
BACKGROUND AND PURPOSE Intracerebral hemorrhage (ICH) is the most adverse event of thrombolysis in ischemic stroke. Cerebral amyloid angiopathy increases the risk for spontaneous lobar ICH. Although thrombolysis may be performed in cerebral amyloid angiopathy-affected patients, there is still little knowledge available on the risk for secondary ICH. METHODS We investigated the effect of recom...
متن کاملRemote Intracerebral Hemorrhage After Intravenous Thrombolysis
Intracerebral hemorrhage (ICH) is the most serious complication of intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV-r-tPA) in patients with ischemic stroke. The European Cooperative Acute Stroke Study (ECASS) defined remote parenchymal hemorrhages (rPH) as single or multiple hemorrhages that appear in brain regions without visible ischemic damage detected by crani...
متن کامل